Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2026)
Revolution Medicines (RVMD) posted Amortizatization of Intangibles of $4.3 million for Q2 2026, up 34.44% on a QoQ basis from $3.2 million in Q1 2026, and down 44.04% year-over-year from $7.7 million in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Amortizatization of Intangibles for 8 years, with the latest figure at $4.3 million in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 44.04% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $17.8 million, a 50.45% decrease from a year earlier, with the FY2025 full-year figure at $27.8 million, down 37.55% from the prior year.
- Amortizatization of Intangibles was $4.3 million for Q2 2026 at Revolution Medicines, up from $3.2 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $15.2 million in Q1 2024, with the low at $1.1 million in Q1 2022.
- Average Amortizatization of Intangibles over 5 years is $5.9 million, with a median of $5.0 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles surged 630.37% in 2023, then plunged 67.17% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at $1.2 million in 2022, then soared by 630.37% to $8.6 million in 2023, then grew by 2.24% to $8.8 million in 2024, then plunged by 48.4% to $4.6 million in 2025, then decreased by 4.85% to $4.3 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $4.3 million (Q2 2026), $3.2 million (Q1 2026), and $4.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 984.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 600.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | 4.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.33 Mn |
| Mar 31, 2026 | 3.22 Mn |
| Dec 31, 2025 | 4.55 Mn |
| Sep 30, 2025 | 5.72 Mn |
| Jun 30, 2025 | 7.74 Mn |
| Mar 31, 2025 | 9.82 Mn |
| Dec 31, 2024 | 8.83 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | 10.90 Mn |
| Mar 31, 2024 | 15.24 Mn |
| Dec 31, 2023 | 8.63 Mn |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 4.85 Mn |
| Mar 31, 2023 | 3.58 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 979,000.00 |
| Sep 30, 2021 | 691,000.00 |
API Access
Revolution Medicines Amortizatization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();